Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control
Abstract
:1. Introduction
1.1. Literature Review
1.2. Selection of Investigated Countries
1.3. The Objectives
2. Materials and Methods
2.1. The Difference-in-Differences Specification
2.2. Estimation of Societal Health Burden in Terms of DALYs
2.3. Estimation of Temporary and Permanent Productivity Losses
3. Results
3.1. COVID-19 Affects Life Expectancy Significantly
3.2. The Pandemic Resulted in Societal Health Burden
3.3. Substantial Temporary and Permanent Productivity Losses
4. Discussion and Policy Implications
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sorci, G.; Faivre, B.; Morand, S. Explaining among-country variation in COVID-19 case fatality rate. Sci. Rep. 2020, 10, 18909. [Google Scholar] [CrossRef] [PubMed]
- Andrasfay, T.; Goldman, N. Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations. Proc. Natl. Acad. Sci. USA 2021, 118, e2014746118. [Google Scholar] [CrossRef] [PubMed]
- Canada Statistics. Available online: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1410001701 (accessed on 30 August 2022).
- Australian Bureau of Statistics. Available online: https://www.abs.gov.au/statistics/labour/employment-and-unemployment/labour-force-australia/latest-release (accessed on 30 August 2022).
- Lopachev, A.V.; Kazanskaya, R.B.; Khutorova, A.V.; Fedorova, T.N. An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment. Eur. J. Pharm. 2020, 886, 173457. [Google Scholar] [CrossRef] [PubMed]
- Jia, J.S.; Lu, X.; Yuan, Y.; Xu, G.; Jia, J.; Christakis, N.A. Population flow drives spatio-temporal distribution of COVID-19 in China. Nature 2020, 582, 389–394. [Google Scholar] [CrossRef] [PubMed]
- Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goolsbee, A.; Syverson, C. Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. J. Public Econ. 2021, 193, 104311. [Google Scholar] [CrossRef] [PubMed]
- Jena, P.R.; Majhi, R.; Kalli, R.; Managi, S.; Majhi, B. Impact of COVID-19 on GDP of major economies: Application of the artificial neural network forecaster. Econ. Anal. Policy 2021, 69, 324–339. [Google Scholar] [CrossRef]
- Huo, C.; Hameed, J.; Nawaz, A.; Shah, S.A.R.; Alqahtani, W.; Maqsoom, A.; Anwar, M.K. Scientific risk performance analysis and development of disaster management framework: A case study of developing Asian countries. J. King Saud Univ. Sci. 2021, 33, 101348. [Google Scholar] [CrossRef] [PubMed]
- Nurchis, M.C.; Pascucci, D.; Sapienza, M.; Villani, L.; D’Ambrosio, F.; Castrini, F.; Specchia, M.L.; Laurenti, P.; Damiani, G. Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss. Int. J. Environ. Res. Public Health 2020, 17, 4233. [Google Scholar] [CrossRef] [PubMed]
- Wang, F.; Wang, J.D. Estimating US Earnings Loss Associated with COVID-19 Based on Human Capital Calculation. Int. J. Environ. Res. Public Health 2022, 19, 1015. [Google Scholar] [CrossRef] [PubMed]
- Wenham, C.; Smith, J.; Morgan, R. COVID-19: The gendered impacts of the outbreak. Lancet 2020, 395, 846–848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Australian Bureau of Statistics. Causes of Death, Australia. 2019. Available online: https://www.abs.gov.au/statistics/health/causes-death/causes-death-australia/2019 (accessed on 21 December 2022).
- Statistics Canada. Leading Causes of Death, Total Population, by Age Group. 2022. Available online: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310039401 (accessed on 21 December 2022).
- Ayyagari, P.; Shane, D.M. Does Prescription Drug Coverage Improve Mental Health? Evid. Medicare Part D. J Health Econ. 2015, 41, 46–58. [Google Scholar] [PubMed]
- Olsen, K.M.; Dahl, S.-Å. Health Differences between European Countries. Soc. Sci. Med. 2007, 64, 1665–1678. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention (CDC). Loss of Work Due to Illness from COVID-19. Available online: http://covid.cdc.gov/covid-data-tracker/#cases_casesinlast7days. (accessed on 1 September 2022).
- World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks; World Health Organization: Geneva, Switzerland, 2009. [Google Scholar]
- Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disability Weights; Institute for Health Metrics and Evaluation (IHME): Seattle, WA, USA, 2020; Available online: https://ghdx.healthdata.org/record/ihme-data/gbd-2019-disability-weights (accessed on 21 December 2022).
- Haagsma, J.A.; Polinder, S.; Cassini, A.; Colzani, E.; Havelaar, A.H. Review of disability weight studies: Comparison of methodological choices and values. Popul. Health Metr. 2014, 12, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Charalampous, P.; Polinder, S.; Wothge, J.; von der Lippe, E.; Haagsma, J.A. A systematic literature review of disability weights measurement studies: Evolution of methodological choices. Arch. Public Health 2022, 80, 91. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Assessing the Environmental Burden of Disease at National and Local Levels: Introduction and Methods. 2003. Available online: https://apps.who.int/iris/bitstream/handle/10665/42750/9241546204.pdf (accessed on 21 December 2022).
- Grosse, S.D.; Krueger, K.V.; Pike, J. Estimated annual and lifetime labor productivity in the United States, 2016: Implications for economic evaluations. J. Med. Econ. 2019, 22, 501–508. [Google Scholar] [CrossRef] [PubMed]
- Sharma, G.; Volgman, A.S.; Michos, E.D. Sex Differences in Mortality From COVID-19 Pandemic: Are Men Vulnerable and Women Protected? JACC Case Rep. 2020, 2, 1407–1410. [Google Scholar] [CrossRef] [PubMed]
- Schöley, J.; Aburto, J.M.; Kashnitsky, I.; Kniffka, M.S.; Zhang, L.; Jaadla, H.; Dowd, J.B.; Kashyap, R. Life expectancy changes since COVID-19. Nat. Hum. Behav. 2022, 6, 1649–1659. [Google Scholar] [CrossRef] [PubMed]
- Deng, Z.; Messacar, D.; Morissette, R. Running the Economy Remotely: Potential for Working from Home during and after COVID-19: Statistics Canada 2020. Available online: https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00026-eng.htm (accessed on 14 December 2022).
- Fabian, E.R.; Babcock, L.; Bilotti, A.; Tolley, G. Design of Contingent Valuation Approaches to Serious Illness. Valuing Health for Policy: An Economic Approached; Tolley, G., Kenkel, D., Fabian, R., Eds.; The University of Chicago Press: Chicago, IL, USA; London, UK, 1994. [Google Scholar]
- Rao, A.M.; Ma, H.T.; Moloney, G.; Kwong, J.C.; Juni, P.; Sander, B.; Kustra, R.; Baral, S.D.; Mishra, S.A. Disproportionate Epidemic: COVID-19 Cases and Deaths among Essential Workers in Toronto, Canada. Ann. Epidemiol. 2021, 63, 63–67. [Google Scholar] [CrossRef] [PubMed]
- O’Donnell, J. Essential Workers during COVID-19: At Risk and Lacking Union Representation 2020. Available online: https://www.brookings.edu/blog/up-front/2020/09/03/essential-workers-during-covid-19-at-risk-and-lacking-union-representation/#:∼:ext=COVID%2D19%20and%20New%20Labor%20Market%20Challenges&text=Recent%20estimates%20suggest%20that%20lowfrom%20home%20than%20their%20peers (accessed on 14 December 2022).
Life Expectancy | Median | Mean | Std. Dev. | Min | Max | |
---|---|---|---|---|---|---|
Ages | ||||||
0–19 | 82.3 | 82.5 | 1.9 | 76.6 | 84.8 | |
male | 80.8 | 80.7 | 0.5 | 79.6 | 81.3 | |
female | 84.4 | 84.3 | 0.5 | 83.3 | 84.8 | |
20–29 | 62.8 | 63 | 1.8 | 60.2 | 65.2 | |
male | 61.3 | 61.3 | 0.5 | 60.2 | 61.7 | |
female | 64.9 | 64.8 | 0.5 | 63.8 | 65.2 | |
30–39 | 53 | 53.3 | 1.7 | 50.7 | 55.4 | |
male | 51.7 | 51.7 | 0.4 | 50.7 | 52.1 | |
female | 55 | 55 | 0.4 | 54 | 55.4 | |
40–49 | 43.4 | 43.7 | 1.6 | 41.2 | 45.6 | |
male | 42.2 | 42.1 | 0.4 | 41.2 | 42.5 | |
female | 45.3 | 45.2 | 0.4 | 44.3 | 45.6 | |
50–59 | 34 | 34.3 | 1.5 | 31.9 | 36 | |
male | 32.9 | 32.8 | 0.4 | 31.9 | 33.2 | |
female | 35.7 | 35.7 | 0.4 | 34.7 | 36 | |
60–69 | 25 | 25.3 | 1.3 | 23.1 | 26.8 | |
male | 24.1 | 24 | 0.4 | 23.1 | 24.4 | |
female | 26.6 | 26.5 | 0.4 | 25.6 | 26.8 | |
70–79 | 16.7 | 16.9 | 0.9 | 15.2 | 18 | |
male | 16 | 16 | 0.3 | 15.2 | 16.2 | |
female | 17.9 | 17.9 | 0.2 | 17.2 | 18 | |
80+ | 9.4 | 9.6 | 0.57 | 8.6 | 10.4 | |
male | 9.2 | 9.1 | 0.2 | 8.6 | 9.2 | |
female | 10.2 | 10.2 | 0.2 | 9.6 | 10.4 |
Ages | 0–19 | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | 80+ | |
---|---|---|---|---|---|---|---|---|---|
Coefficients | |||||||||
β | −0.996 * | −0.88 * | −0.781 * | −0.723 * | −0.732 * | −0.655 * | −0.374 * | −0.049 | |
(0.029) | (0.029) | (0.029) | (0.029) | (0.028) | (0.028) | (0.027) | (0.026) | ||
γ | 3.624 * | 3.524 * | 3.295 * | 3.067 * | 2.832 * | 2.503 * | 1.899 * | 1.091 * | |
(0.029) | (0.029) | (0.029) | (0.029) | (0.028) | (0.028) | (0.027) | (0.026) | ||
ϕ | −0.209 * | −0.209 * | −0.209 * | −0.207 * | −0.204 * | −0.199 * | −0.191 * | −0.181 * | |
(0.029) | (0.029) | (0.029) | (0.029) | (0.028) | (0.028) | (0.027) | (0.026) | ||
α | 81.32 * | 61.71 * | 52.16 * | 42.61 * | 33.3 * | 24.43 * | 16.25 * | 9.213 * | |
(0.029) | (0.029) | (0.029) | (0.029) | (0.028) | (0.028) | (0.027) | (0.026) |
Loss in DALYs | Male (per 1000) | Female (per 1000) | |||||
---|---|---|---|---|---|---|---|
Ages | YLLs | YLDs | DALYs | YLLs | YLDs | DALYs | |
0–19 | 0.032 | 0.134 | 0.166 | 0.041 | 0.129 | 0.17 | |
20–29 | 0.117 | 0.131 | 0.248 | 0.077 | 0.154 | 0.231 | |
30–39 | 0.24 | 0.113 | 0.353 | 0.157 | 0.139 | 0.296 | |
40–49 | 0.411 | 0.086 | 0.497 | 0.248 | 0.104 | 0.352 | |
50–59 | 0.829 | 0.064 | 0.893 | 0.538 | 0.068 | 0.606 | |
60–69 | 1.33 | 0.036 | 1.366 | 0.797 | 0.033 | 0.83 | |
70–79 | 1.454 | 0.018 | 1.472 | 1.003 | 0.016 | 1.019 | |
80+ | 1.484 | 0.014 | 1.498 | 1.793 | 0.019 | 1.812 | |
total | 5.897 | 0.596 | 6.493 | 4.654 | 0.662 | 5.316 |
Sex | Ages | TPL (Temporary Productivity Loss) | Total TPL/GDP (%) | PPL (Permanent Productivity Loss) | Total PPL/GDP (%) | ||||
---|---|---|---|---|---|---|---|---|---|
Estimated No. Incidence Cases | TPL per Case | Total TPL (× 103 US$) | Estimated No. Mortality Cases | PPL per Case | Total PPL (× 103 US$) | ||||
Male | 15–24 | 254,253 | 685 | 174,066 | 0.0100 | 38 | 247,055 | 9388 | 0.0005 |
25–34 | 314,358 | 2000 | 628,716 | 0.0361 | 123 | 1,029,123 | 126,582 | 0.0073 | |
35–44 | 272,658 | 2692 | 734,079 | 0.0422 | 279 | 1,251,061 | 349,046 | 0.0201 | |
45–54 | 229,905 | 3104 | 713,590 | 0.0410 | 713 | 1,091,788 | 778,445 | 0.0447 | |
55–64 | 191,017 | 2585 | 493,706 | 0.0284 | 2035 | 430,490 | 876,047 | 0.0503 | |
65–69 | 63,522 | 1862 | 118,249 | 0.0068 | 1205 | 82,011 | 98,823 | 0.0003 | |
Female | 15–24 | 277,983 | 600 | 166,790 | 0.0096 | 27 | 221,319 | 5976 | 0.0057 |
25–34 | 379,448 | 1615 | 612,955 | 0.0352 | 80 | 779,999 | 62,400 | 0.0036 | |
35–44 | 341,384 | 2000 | 682,768 | 0.0392 | 173 | 834,830 | 144,426 | 0.0083 | |
45–54 | 273,217 | 2162 | 590,569 | 0.0339 | 445 | 698,061 | 310,637 | 0.0179 | |
55–64 | 202,263 | 1665 | 336,846 | 0.0194 | 1192 | 231,758 | 276,255 | 0.0159 | |
65–69 | 63,142 | 1362 | 85,970 | 0.0049 | 702 | 38,120 | 26,760 | 0.0015 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wang, F.; Lui, J.; Wang, J.-D. Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control. Int. J. Environ. Res. Public Health 2023, 20, 2419. https://doi.org/10.3390/ijerph20032419
Wang F, Lui J, Wang J-D. Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control. International Journal of Environmental Research and Public Health. 2023; 20(3):2419. https://doi.org/10.3390/ijerph20032419
Chicago/Turabian StyleWang, Fuhmei, Jinwei Lui, and Jung-Der Wang. 2023. "Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control" International Journal of Environmental Research and Public Health 20, no. 3: 2419. https://doi.org/10.3390/ijerph20032419
APA StyleWang, F., Lui, J., & Wang, J. -D. (2023). Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control. International Journal of Environmental Research and Public Health, 20(3), 2419. https://doi.org/10.3390/ijerph20032419